Global Pet Intestinal Medicine Market Growth 2026-2032
The global Pet Intestinal Medicine market size is predicted to grow from US$ 741 million in 2025 to US$ 1122 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
LP Information, Inc. (LPI) ' newest research report, the ?Pet Intestinal Medicine Industry Forecast? looks at past sales and reviews total world Pet Intestinal Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet Intestinal Medicine sales for 2026 through 2032. With Pet Intestinal Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Intestinal Medicine industry.
This Insight Report provides a comprehensive analysis of the global Pet Intestinal Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Intestinal Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pet Intestinal Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Intestinal Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Intestinal Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Intestinal Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
LP Information, Inc. (LPI) ' newest research report, the ?Pet Intestinal Medicine Industry Forecast? looks at past sales and reviews total world Pet Intestinal Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet Intestinal Medicine sales for 2026 through 2032. With Pet Intestinal Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Intestinal Medicine industry.
This Insight Report provides a comprehensive analysis of the global Pet Intestinal Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Intestinal Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pet Intestinal Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Intestinal Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Intestinal Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Intestinal Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Powder
- Liquid
- Cat
- Dog
- Reptile
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Boehringer Ingelheim
- Merck
- Elanco
- Virbac
- Dechra Veterinary Products
- Ceva
- Vetoquinol
- Ouro Fino Saude
- Norbrook
- Jindun
- Wuhan chopperlvya
- CAHIC
- What is the 10-year outlook for the global Pet Intestinal Medicine market?
- What factors are driving Pet Intestinal Medicine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Pet Intestinal Medicine market opportunities vary by end market size?
- How does Pet Intestinal Medicine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Intestinal Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pet Intestinal Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pet Intestinal Medicine by Country/Region, 2021, 2025 & 2032
2.2 Pet Intestinal Medicine Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Pet Intestinal Medicine Sales by Type
2.2.3.1 Global Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pet Intestinal Medicine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pet Intestinal Medicine Sale Price by Type (2021-2026)
2.3 Pet Intestinal Medicine Segment by Application
2.3.1 Cat
2.3.2 Dog
2.3.3 Reptile
2.3.4 Other
2.3.5 Pet Intestinal Medicine Sales by Application
2.3.5.1 Global Pet Intestinal Medicine Sale Market Share by Application (2021-2026)
2.3.5.2 Global Pet Intestinal Medicine Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Pet Intestinal Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pet Intestinal Medicine Breakdown Data by Company
3.1.1 Global Pet Intestinal Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Pet Intestinal Medicine Sales Market Share by Company (2021-2026)
3.2 Global Pet Intestinal Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Pet Intestinal Medicine Revenue by Company (2021-2026)
3.2.2 Global Pet Intestinal Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Pet Intestinal Medicine Sale Price by Company
3.4 Key Manufacturers Pet Intestinal Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Intestinal Medicine Product Location Distribution
3.4.2 Players Pet Intestinal Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET INTESTINAL MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Pet Intestinal Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pet Intestinal Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pet Intestinal Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pet Intestinal Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Pet Intestinal Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pet Intestinal Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pet Intestinal Medicine Sales Growth
4.4 APAC Pet Intestinal Medicine Sales Growth
4.5 Europe Pet Intestinal Medicine Sales Growth
4.6 Middle East & Africa Pet Intestinal Medicine Sales Growth
5 AMERICAS
5.1 Americas Pet Intestinal Medicine Sales by Country
5.1.1 Americas Pet Intestinal Medicine Sales by Country (2021-2026)
5.1.2 Americas Pet Intestinal Medicine Revenue by Country (2021-2026)
5.2 Americas Pet Intestinal Medicine Sales by Type (2021-2026)
5.3 Americas Pet Intestinal Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Intestinal Medicine Sales by Region
6.1.1 APAC Pet Intestinal Medicine Sales by Region (2021-2026)
6.1.2 APAC Pet Intestinal Medicine Revenue by Region (2021-2026)
6.2 APAC Pet Intestinal Medicine Sales by Type (2021-2026)
6.3 APAC Pet Intestinal Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Intestinal Medicine by Country
7.1.1 Europe Pet Intestinal Medicine Sales by Country (2021-2026)
7.1.2 Europe Pet Intestinal Medicine Revenue by Country (2021-2026)
7.2 Europe Pet Intestinal Medicine Sales by Type (2021-2026)
7.3 Europe Pet Intestinal Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Intestinal Medicine by Country
8.1.1 Middle East & Africa Pet Intestinal Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pet Intestinal Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pet Intestinal Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Pet Intestinal Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Intestinal Medicine
10.3 Manufacturing Process Analysis of Pet Intestinal Medicine
10.4 Industry Chain Structure of Pet Intestinal Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Intestinal Medicine Distributors
11.3 Pet Intestinal Medicine Customer
12 WORLD FORECAST REVIEW FOR PET INTESTINAL MEDICINE BY GEOGRAPHIC REGION
12.1 Global Pet Intestinal Medicine Market Size Forecast by Region
12.1.1 Global Pet Intestinal Medicine Forecast by Region (2027-2032)
12.1.2 Global Pet Intestinal Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pet Intestinal Medicine Forecast by Type (2027-2032)
12.7 Global Pet Intestinal Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet Intestinal Medicine Product Portfolios and Specifications
13.1.3 Zoetis Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Pet Intestinal Medicine Product Portfolios and Specifications
13.3.3 Merck Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Pet Intestinal Medicine Product Portfolios and Specifications
13.4.3 Elanco Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Pet Intestinal Medicine Product Portfolios and Specifications
13.5.3 Virbac Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Intestinal Medicine Product Portfolios and Specifications
13.7.3 Ceva Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Pet Intestinal Medicine Product Portfolios and Specifications
13.8.3 Vetoquinol Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Ouro Fino Saude
13.9.1 Ouro Fino Saude Company Information
13.9.2 Ouro Fino Saude Pet Intestinal Medicine Product Portfolios and Specifications
13.9.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ouro Fino Saude Main Business Overview
13.9.5 Ouro Fino Saude Latest Developments
13.10 Norbrook
13.10.1 Norbrook Company Information
13.10.2 Norbrook Pet Intestinal Medicine Product Portfolios and Specifications
13.10.3 Norbrook Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Norbrook Main Business Overview
13.10.5 Norbrook Latest Developments
13.11 Jindun
13.11.1 Jindun Company Information
13.11.2 Jindun Pet Intestinal Medicine Product Portfolios and Specifications
13.11.3 Jindun Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jindun Main Business Overview
13.11.5 Jindun Latest Developments
13.12 Wuhan chopperlvya
13.12.1 Wuhan chopperlvya Company Information
13.12.2 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolios and Specifications
13.12.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Wuhan chopperlvya Main Business Overview
13.12.5 Wuhan chopperlvya Latest Developments
13.13 CAHIC
13.13.1 CAHIC Company Information
13.13.2 CAHIC Pet Intestinal Medicine Product Portfolios and Specifications
13.13.3 CAHIC Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 CAHIC Main Business Overview
13.13.5 CAHIC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Intestinal Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pet Intestinal Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pet Intestinal Medicine by Country/Region, 2021, 2025 & 2032
2.2 Pet Intestinal Medicine Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Pet Intestinal Medicine Sales by Type
2.2.3.1 Global Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pet Intestinal Medicine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pet Intestinal Medicine Sale Price by Type (2021-2026)
2.3 Pet Intestinal Medicine Segment by Application
2.3.1 Cat
2.3.2 Dog
2.3.3 Reptile
2.3.4 Other
2.3.5 Pet Intestinal Medicine Sales by Application
2.3.5.1 Global Pet Intestinal Medicine Sale Market Share by Application (2021-2026)
2.3.5.2 Global Pet Intestinal Medicine Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Pet Intestinal Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pet Intestinal Medicine Breakdown Data by Company
3.1.1 Global Pet Intestinal Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Pet Intestinal Medicine Sales Market Share by Company (2021-2026)
3.2 Global Pet Intestinal Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Pet Intestinal Medicine Revenue by Company (2021-2026)
3.2.2 Global Pet Intestinal Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Pet Intestinal Medicine Sale Price by Company
3.4 Key Manufacturers Pet Intestinal Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Intestinal Medicine Product Location Distribution
3.4.2 Players Pet Intestinal Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET INTESTINAL MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Pet Intestinal Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pet Intestinal Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pet Intestinal Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pet Intestinal Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Pet Intestinal Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pet Intestinal Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pet Intestinal Medicine Sales Growth
4.4 APAC Pet Intestinal Medicine Sales Growth
4.5 Europe Pet Intestinal Medicine Sales Growth
4.6 Middle East & Africa Pet Intestinal Medicine Sales Growth
5 AMERICAS
5.1 Americas Pet Intestinal Medicine Sales by Country
5.1.1 Americas Pet Intestinal Medicine Sales by Country (2021-2026)
5.1.2 Americas Pet Intestinal Medicine Revenue by Country (2021-2026)
5.2 Americas Pet Intestinal Medicine Sales by Type (2021-2026)
5.3 Americas Pet Intestinal Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Intestinal Medicine Sales by Region
6.1.1 APAC Pet Intestinal Medicine Sales by Region (2021-2026)
6.1.2 APAC Pet Intestinal Medicine Revenue by Region (2021-2026)
6.2 APAC Pet Intestinal Medicine Sales by Type (2021-2026)
6.3 APAC Pet Intestinal Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Intestinal Medicine by Country
7.1.1 Europe Pet Intestinal Medicine Sales by Country (2021-2026)
7.1.2 Europe Pet Intestinal Medicine Revenue by Country (2021-2026)
7.2 Europe Pet Intestinal Medicine Sales by Type (2021-2026)
7.3 Europe Pet Intestinal Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Intestinal Medicine by Country
8.1.1 Middle East & Africa Pet Intestinal Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pet Intestinal Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pet Intestinal Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Pet Intestinal Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Intestinal Medicine
10.3 Manufacturing Process Analysis of Pet Intestinal Medicine
10.4 Industry Chain Structure of Pet Intestinal Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Intestinal Medicine Distributors
11.3 Pet Intestinal Medicine Customer
12 WORLD FORECAST REVIEW FOR PET INTESTINAL MEDICINE BY GEOGRAPHIC REGION
12.1 Global Pet Intestinal Medicine Market Size Forecast by Region
12.1.1 Global Pet Intestinal Medicine Forecast by Region (2027-2032)
12.1.2 Global Pet Intestinal Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pet Intestinal Medicine Forecast by Type (2027-2032)
12.7 Global Pet Intestinal Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet Intestinal Medicine Product Portfolios and Specifications
13.1.3 Zoetis Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Pet Intestinal Medicine Product Portfolios and Specifications
13.3.3 Merck Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Pet Intestinal Medicine Product Portfolios and Specifications
13.4.3 Elanco Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Pet Intestinal Medicine Product Portfolios and Specifications
13.5.3 Virbac Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Intestinal Medicine Product Portfolios and Specifications
13.7.3 Ceva Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Pet Intestinal Medicine Product Portfolios and Specifications
13.8.3 Vetoquinol Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Ouro Fino Saude
13.9.1 Ouro Fino Saude Company Information
13.9.2 Ouro Fino Saude Pet Intestinal Medicine Product Portfolios and Specifications
13.9.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ouro Fino Saude Main Business Overview
13.9.5 Ouro Fino Saude Latest Developments
13.10 Norbrook
13.10.1 Norbrook Company Information
13.10.2 Norbrook Pet Intestinal Medicine Product Portfolios and Specifications
13.10.3 Norbrook Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Norbrook Main Business Overview
13.10.5 Norbrook Latest Developments
13.11 Jindun
13.11.1 Jindun Company Information
13.11.2 Jindun Pet Intestinal Medicine Product Portfolios and Specifications
13.11.3 Jindun Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jindun Main Business Overview
13.11.5 Jindun Latest Developments
13.12 Wuhan chopperlvya
13.12.1 Wuhan chopperlvya Company Information
13.12.2 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolios and Specifications
13.12.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Wuhan chopperlvya Main Business Overview
13.12.5 Wuhan chopperlvya Latest Developments
13.13 CAHIC
13.13.1 CAHIC Company Information
13.13.2 CAHIC Pet Intestinal Medicine Product Portfolios and Specifications
13.13.3 CAHIC Pet Intestinal Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 CAHIC Main Business Overview
13.13.5 CAHIC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet Intestinal Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pet Intestinal Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 6. Global Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Table 7. Global Pet Intestinal Medicine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2026)
Table 9. Global Pet Intestinal Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pet Intestinal Medicine Sale by Application (2021-2026) & (K Units)
Table 11. Global Pet Intestinal Medicine Sale Market Share by Application (2021-2026)
Table 12. Global Pet Intestinal Medicine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pet Intestinal Medicine Revenue Market Share by Application (2021-2026)
Table 14. Global Pet Intestinal Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pet Intestinal Medicine Sales by Company (2021-2026) & (K Units)
Table 16. Global Pet Intestinal Medicine Sales Market Share by Company (2021-2026)
Table 17. Global Pet Intestinal Medicine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pet Intestinal Medicine Revenue Market Share by Company (2021-2026)
Table 19. Global Pet Intestinal Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pet Intestinal Medicine Producing Area Distribution and Sales Area
Table 21. Players Pet Intestinal Medicine Products Offered
Table 22. Pet Intestinal Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pet Intestinal Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pet Intestinal Medicine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pet Intestinal Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pet Intestinal Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pet Intestinal Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pet Intestinal Medicine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pet Intestinal Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pet Intestinal Medicine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pet Intestinal Medicine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pet Intestinal Medicine Sales Market Share by Country (2021-2026)
Table 35. Americas Pet Intestinal Medicine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pet Intestinal Medicine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pet Intestinal Medicine Sales Market Share by Region (2021-2026)
Table 40. APAC Pet Intestinal Medicine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pet Intestinal Medicine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pet Intestinal Medicine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pet Intestinal Medicine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pet Intestinal Medicine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pet Intestinal Medicine
Table 52. Key Market Challenges & Risks of Pet Intestinal Medicine
Table 53. Key Industry Trends of Pet Intestinal Medicine
Table 54. Pet Intestinal Medicine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pet Intestinal Medicine Distributors List
Table 57. Pet Intestinal Medicine Customer List
Table 58. Global Pet Intestinal Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pet Intestinal Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pet Intestinal Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pet Intestinal Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pet Intestinal Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pet Intestinal Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pet Intestinal Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pet Intestinal Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pet Intestinal Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pet Intestinal Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pet Intestinal Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Pet Intestinal Medicine Product Portfolios and Specifications
Table 74. Zoetis Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Pet Intestinal Medicine Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Merck Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Pet Intestinal Medicine Product Portfolios and Specifications
Table 84. Merck Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Elanco Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Pet Intestinal Medicine Product Portfolios and Specifications
Table 89. Elanco Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elanco Main Business
Table 91. Elanco Latest Developments
Table 92. Virbac Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Virbac Pet Intestinal Medicine Product Portfolios and Specifications
Table 94. Virbac Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Virbac Main Business
Table 96. Virbac Latest Developments
Table 97. Dechra Veterinary Products Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. Dechra Veterinary Products Pet Intestinal Medicine Product Portfolios and Specifications
Table 99. Dechra Veterinary Products Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dechra Veterinary Products Main Business
Table 101. Dechra Veterinary Products Latest Developments
Table 102. Ceva Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Pet Intestinal Medicine Product Portfolios and Specifications
Table 104. Ceva Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ceva Main Business
Table 106. Ceva Latest Developments
Table 107. Vetoquinol Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Vetoquinol Pet Intestinal Medicine Product Portfolios and Specifications
Table 109. Vetoquinol Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Vetoquinol Main Business
Table 111. Vetoquinol Latest Developments
Table 112. Ouro Fino Saude Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Ouro Fino Saude Pet Intestinal Medicine Product Portfolios and Specifications
Table 114. Ouro Fino Saude Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Ouro Fino Saude Main Business
Table 116. Ouro Fino Saude Latest Developments
Table 117. Norbrook Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Norbrook Pet Intestinal Medicine Product Portfolios and Specifications
Table 119. Norbrook Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Norbrook Main Business
Table 121. Norbrook Latest Developments
Table 122. Jindun Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 123. Jindun Pet Intestinal Medicine Product Portfolios and Specifications
Table 124. Jindun Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jindun Main Business
Table 126. Jindun Latest Developments
Table 127. Wuhan chopperlvya Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 128. Wuhan chopperlvya Pet Intestinal Medicine Product Portfolios and Specifications
Table 129. Wuhan chopperlvya Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Wuhan chopperlvya Main Business
Table 131. Wuhan chopperlvya Latest Developments
Table 132. CAHIC Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 133. CAHIC Pet Intestinal Medicine Product Portfolios and Specifications
Table 134. CAHIC Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. CAHIC Main Business
Table 136. CAHIC Latest Developments
Table 1. Pet Intestinal Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pet Intestinal Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 6. Global Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Table 7. Global Pet Intestinal Medicine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2026)
Table 9. Global Pet Intestinal Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pet Intestinal Medicine Sale by Application (2021-2026) & (K Units)
Table 11. Global Pet Intestinal Medicine Sale Market Share by Application (2021-2026)
Table 12. Global Pet Intestinal Medicine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pet Intestinal Medicine Revenue Market Share by Application (2021-2026)
Table 14. Global Pet Intestinal Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pet Intestinal Medicine Sales by Company (2021-2026) & (K Units)
Table 16. Global Pet Intestinal Medicine Sales Market Share by Company (2021-2026)
Table 17. Global Pet Intestinal Medicine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pet Intestinal Medicine Revenue Market Share by Company (2021-2026)
Table 19. Global Pet Intestinal Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pet Intestinal Medicine Producing Area Distribution and Sales Area
Table 21. Players Pet Intestinal Medicine Products Offered
Table 22. Pet Intestinal Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pet Intestinal Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pet Intestinal Medicine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pet Intestinal Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pet Intestinal Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pet Intestinal Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pet Intestinal Medicine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pet Intestinal Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pet Intestinal Medicine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pet Intestinal Medicine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pet Intestinal Medicine Sales Market Share by Country (2021-2026)
Table 35. Americas Pet Intestinal Medicine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pet Intestinal Medicine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pet Intestinal Medicine Sales Market Share by Region (2021-2026)
Table 40. APAC Pet Intestinal Medicine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pet Intestinal Medicine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pet Intestinal Medicine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pet Intestinal Medicine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pet Intestinal Medicine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pet Intestinal Medicine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pet Intestinal Medicine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pet Intestinal Medicine
Table 52. Key Market Challenges & Risks of Pet Intestinal Medicine
Table 53. Key Industry Trends of Pet Intestinal Medicine
Table 54. Pet Intestinal Medicine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pet Intestinal Medicine Distributors List
Table 57. Pet Intestinal Medicine Customer List
Table 58. Global Pet Intestinal Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pet Intestinal Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pet Intestinal Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pet Intestinal Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pet Intestinal Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pet Intestinal Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pet Intestinal Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pet Intestinal Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pet Intestinal Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pet Intestinal Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pet Intestinal Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Pet Intestinal Medicine Product Portfolios and Specifications
Table 74. Zoetis Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Pet Intestinal Medicine Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Merck Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Pet Intestinal Medicine Product Portfolios and Specifications
Table 84. Merck Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Elanco Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Pet Intestinal Medicine Product Portfolios and Specifications
Table 89. Elanco Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elanco Main Business
Table 91. Elanco Latest Developments
Table 92. Virbac Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Virbac Pet Intestinal Medicine Product Portfolios and Specifications
Table 94. Virbac Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Virbac Main Business
Table 96. Virbac Latest Developments
Table 97. Dechra Veterinary Products Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. Dechra Veterinary Products Pet Intestinal Medicine Product Portfolios and Specifications
Table 99. Dechra Veterinary Products Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dechra Veterinary Products Main Business
Table 101. Dechra Veterinary Products Latest Developments
Table 102. Ceva Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Pet Intestinal Medicine Product Portfolios and Specifications
Table 104. Ceva Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ceva Main Business
Table 106. Ceva Latest Developments
Table 107. Vetoquinol Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Vetoquinol Pet Intestinal Medicine Product Portfolios and Specifications
Table 109. Vetoquinol Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Vetoquinol Main Business
Table 111. Vetoquinol Latest Developments
Table 112. Ouro Fino Saude Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Ouro Fino Saude Pet Intestinal Medicine Product Portfolios and Specifications
Table 114. Ouro Fino Saude Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Ouro Fino Saude Main Business
Table 116. Ouro Fino Saude Latest Developments
Table 117. Norbrook Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Norbrook Pet Intestinal Medicine Product Portfolios and Specifications
Table 119. Norbrook Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Norbrook Main Business
Table 121. Norbrook Latest Developments
Table 122. Jindun Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 123. Jindun Pet Intestinal Medicine Product Portfolios and Specifications
Table 124. Jindun Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jindun Main Business
Table 126. Jindun Latest Developments
Table 127. Wuhan chopperlvya Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 128. Wuhan chopperlvya Pet Intestinal Medicine Product Portfolios and Specifications
Table 129. Wuhan chopperlvya Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Wuhan chopperlvya Main Business
Table 131. Wuhan chopperlvya Latest Developments
Table 132. CAHIC Basic Information, Pet Intestinal Medicine Manufacturing Base, Sales Area and Its Competitors
Table 133. CAHIC Pet Intestinal Medicine Product Portfolios and Specifications
Table 134. CAHIC Pet Intestinal Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. CAHIC Main Business
Table 136. CAHIC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet Intestinal Medicine
Figure 2. Pet Intestinal Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Intestinal Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pet Intestinal Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pet Intestinal Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pet Intestinal Medicine Sales Market Share by Country/Region (2025)
Figure 10. Pet Intestinal Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Pet Intestinal Medicine Sales Market Share by Type in 2026
Figure 14. Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2026)
Figure 15. Pet Intestinal Medicine Consumed in Cat
Figure 16. Global Pet Intestinal Medicine Market: Cat (2021-2026) & (K Units)
Figure 17. Pet Intestinal Medicine Consumed in Dog
Figure 18. Global Pet Intestinal Medicine Market: Dog (2021-2026) & (K Units)
Figure 19. Pet Intestinal Medicine Consumed in Reptile
Figure 20. Global Pet Intestinal Medicine Market: Reptile (2021-2026) & (K Units)
Figure 21. Pet Intestinal Medicine Consumed in Other
Figure 22. Global Pet Intestinal Medicine Market: Other (2021-2026) & (K Units)
Figure 23. Global Pet Intestinal Medicine Sale Market Share by Application (2025)
Figure 24. Global Pet Intestinal Medicine Revenue Market Share by Application in 2026
Figure 25. Pet Intestinal Medicine Sales by Company in 2026 (K Units)
Figure 26. Global Pet Intestinal Medicine Sales Market Share by Company in 2026
Figure 27. Pet Intestinal Medicine Revenue by Company in 2026 ($ millions)
Figure 28. Global Pet Intestinal Medicine Revenue Market Share by Company in 2026
Figure 29. Global Pet Intestinal Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Pet Intestinal Medicine Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 32. Americas Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 33. APAC Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 34. APAC Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 35. Europe Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 36. Europe Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 39. Americas Pet Intestinal Medicine Sales Market Share by Country in 2026
Figure 40. Americas Pet Intestinal Medicine Revenue Market Share by Country (2021-2026)
Figure 41. Americas Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 42. Americas Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 43. United States Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Pet Intestinal Medicine Sales Market Share by Region in 2026
Figure 48. APAC Pet Intestinal Medicine Revenue Market Share by Region (2021-2026)
Figure 49. APAC Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 50. APAC Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 51. China Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. India Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Pet Intestinal Medicine Sales Market Share by Country in 2026
Figure 59. Europe Pet Intestinal Medicine Revenue Market Share by Country (2021-2026)
Figure 60. Europe Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 61. Europe Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 62. Germany Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. France Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 70. Egypt Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Pet Intestinal Medicine in 2026
Figure 76. Manufacturing Process Analysis of Pet Intestinal Medicine
Figure 77. Industry Chain Structure of Pet Intestinal Medicine
Figure 78. Channels of Distribution
Figure 79. Global Pet Intestinal Medicine Sales Market Forecast by Region (2027-2032)
Figure 80. Global Pet Intestinal Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Pet Intestinal Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Pet Intestinal Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Pet Intestinal Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Pet Intestinal Medicine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pet Intestinal Medicine
Figure 2. Pet Intestinal Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Intestinal Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pet Intestinal Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pet Intestinal Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pet Intestinal Medicine Sales Market Share by Country/Region (2025)
Figure 10. Pet Intestinal Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Pet Intestinal Medicine Sales Market Share by Type in 2026
Figure 14. Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2026)
Figure 15. Pet Intestinal Medicine Consumed in Cat
Figure 16. Global Pet Intestinal Medicine Market: Cat (2021-2026) & (K Units)
Figure 17. Pet Intestinal Medicine Consumed in Dog
Figure 18. Global Pet Intestinal Medicine Market: Dog (2021-2026) & (K Units)
Figure 19. Pet Intestinal Medicine Consumed in Reptile
Figure 20. Global Pet Intestinal Medicine Market: Reptile (2021-2026) & (K Units)
Figure 21. Pet Intestinal Medicine Consumed in Other
Figure 22. Global Pet Intestinal Medicine Market: Other (2021-2026) & (K Units)
Figure 23. Global Pet Intestinal Medicine Sale Market Share by Application (2025)
Figure 24. Global Pet Intestinal Medicine Revenue Market Share by Application in 2026
Figure 25. Pet Intestinal Medicine Sales by Company in 2026 (K Units)
Figure 26. Global Pet Intestinal Medicine Sales Market Share by Company in 2026
Figure 27. Pet Intestinal Medicine Revenue by Company in 2026 ($ millions)
Figure 28. Global Pet Intestinal Medicine Revenue Market Share by Company in 2026
Figure 29. Global Pet Intestinal Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Pet Intestinal Medicine Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 32. Americas Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 33. APAC Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 34. APAC Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 35. Europe Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 36. Europe Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Pet Intestinal Medicine Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Pet Intestinal Medicine Revenue 2021-2026 ($ millions)
Figure 39. Americas Pet Intestinal Medicine Sales Market Share by Country in 2026
Figure 40. Americas Pet Intestinal Medicine Revenue Market Share by Country (2021-2026)
Figure 41. Americas Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 42. Americas Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 43. United States Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Pet Intestinal Medicine Sales Market Share by Region in 2026
Figure 48. APAC Pet Intestinal Medicine Revenue Market Share by Region (2021-2026)
Figure 49. APAC Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 50. APAC Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 51. China Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. India Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Pet Intestinal Medicine Sales Market Share by Country in 2026
Figure 59. Europe Pet Intestinal Medicine Revenue Market Share by Country (2021-2026)
Figure 60. Europe Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 61. Europe Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 62. Germany Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. France Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Application (2021-2026)
Figure 70. Egypt Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Pet Intestinal Medicine Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Pet Intestinal Medicine in 2026
Figure 76. Manufacturing Process Analysis of Pet Intestinal Medicine
Figure 77. Industry Chain Structure of Pet Intestinal Medicine
Figure 78. Channels of Distribution
Figure 79. Global Pet Intestinal Medicine Sales Market Forecast by Region (2027-2032)
Figure 80. Global Pet Intestinal Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Pet Intestinal Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Pet Intestinal Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Pet Intestinal Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Pet Intestinal Medicine Revenue Market Share Forecast by Application (2027-2032)
